MARATTO

preprint · Research Square

First Field Use of the Pentavalent Meningococcal Conjugate Vaccine (Men5CV) in Response to a Serogroup C Meningitis Outbreak: Evidence from Yobe State, Northeastern Nigeria

2026Open accessGombe State University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Bacterial Infections and Vaccines
  • vaccines and immunoinformatics approaches
  • Virology and Viral Diseases

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21203/rs.3.rs-8262447/v1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.